Nanomedicine and medicinal plants: emerging symbiosis in managing lung diseases and associated infections

Keshav Raj Paudel; Gabriele De Rubis; Nisha Panth; Sachin Kumar Singh; Dinesh Kumar Chellappan; Philip Michael Hansbro; Kamal Dua

doi:10.17179/excli2022-5376

Nanomedicine and medicinal plants: emerging symbiosis in managing lung diseases and associated infections

Keshav Raj Paudel
, Gabriele De Rubis
, Nisha Panth
, Sachin Kumar Singh
, Dinesh Kumar Chellappan
, Philip Michael Hansbro
, Kamal Dua

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

1 Downloads (Pure)

Abstract

Pulmonary diseases refer to a broad category of diseases (both acute and chronic) related to the lungs that include asthma, acute lung injury, chronic obstructive pulmonary disease (COPD), pulmonary hypertension, pulmonary fibrosis, and lung cancer. These diseases affect a significant percentage of the global population (Paudel et al., 2021a). Medicinal plants are gaining massive attention as promising therapeutics in alleviating respiratory diseases (Chan et al., 2021a; Prasher et al., 2020).

Original language	English
Pages (from-to)	1299-1303
Number of pages	5
Journal	EXCLI Journal
Volume	21
DOIs	https://doi.org/10.17179/excli2022-5376
Publication status	Published - Oct 2022
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.17179/excli2022-5376Licence: CC BY

Full textFinal published version, 393 KBLicence: CC BY

Cite this

@article{9536dabc77324626b5e558cd66a8f4e0,

title = "Nanomedicine and medicinal plants: emerging symbiosis in managing lung diseases and associated infections",

abstract = "Pulmonary diseases refer to a broad category of diseases (both acute and chronic) related to the lungs that include asthma, acute lung injury, chronic obstructive pulmonary disease (COPD), pulmonary hypertension, pulmonary fibrosis, and lung cancer. These diseases affect a significant percentage of the global population (Paudel et al., 2021a). Medicinal plants are gaining massive attention as promising therapeutics in alleviating respiratory diseases (Chan et al., 2021a; Prasher et al., 2020).",

author = "Paudel, \{Keshav Raj\} and \{De Rubis\}, Gabriele and Nisha Panth and Singh, \{Sachin Kumar\} and Chellappan, \{Dinesh Kumar\} and Hansbro, \{Philip Michael\} and Kamal Dua",

year = "2022",

month = oct,

doi = "10.17179/excli2022-5376",

language = "English",

volume = "21",

pages = "1299--1303",

journal = "EXCLI Journal",

issn = "1611-2156",

publisher = "Leibniz Research Centre for Working Environment and Human Factors",

}

TY - JOUR

T1 - Nanomedicine and medicinal plants

T2 - emerging symbiosis in managing lung diseases and associated infections

AU - Paudel, Keshav Raj

AU - De Rubis, Gabriele

AU - Panth, Nisha

AU - Singh, Sachin Kumar

AU - Chellappan, Dinesh Kumar

AU - Hansbro, Philip Michael

AU - Dua, Kamal

PY - 2022/10

Y1 - 2022/10

N2 - Pulmonary diseases refer to a broad category of diseases (both acute and chronic) related to the lungs that include asthma, acute lung injury, chronic obstructive pulmonary disease (COPD), pulmonary hypertension, pulmonary fibrosis, and lung cancer. These diseases affect a significant percentage of the global population (Paudel et al., 2021a). Medicinal plants are gaining massive attention as promising therapeutics in alleviating respiratory diseases (Chan et al., 2021a; Prasher et al., 2020).

AB - Pulmonary diseases refer to a broad category of diseases (both acute and chronic) related to the lungs that include asthma, acute lung injury, chronic obstructive pulmonary disease (COPD), pulmonary hypertension, pulmonary fibrosis, and lung cancer. These diseases affect a significant percentage of the global population (Paudel et al., 2021a). Medicinal plants are gaining massive attention as promising therapeutics in alleviating respiratory diseases (Chan et al., 2021a; Prasher et al., 2020).

UR - https://www.scopus.com/pages/publications/85140454077

U2 - 10.17179/excli2022-5376

DO - 10.17179/excli2022-5376

M3 - Article

AN - SCOPUS:85140454077

SN - 1611-2156

VL - 21

SP - 1299

EP - 1303

JO - EXCLI Journal

JF - EXCLI Journal

ER -

Nanomedicine and medicinal plants: emerging symbiosis in managing lung diseases and associated infections

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this